Fish Skin Disease Market

Fish Skin Disease Market, By Type of disease (Bacterial Infections, Parasitic Infections, Viral Infections, Fungal Infections), By Treatment type (Antibiotics, Vaccines, Probiotics, Phage Therapy, Other Natural Treatments), By Fish species (Talmon, Trout, Tilapia, Catfish, Others), By End user (Aquaculture Producers, Fisheries, Other organizations involved in fish production) , and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Ichthyosis is a medical condition that causes widespread and persistent thick, dry, fish-scale skin. It is a group of skin disorders that lead to dry and itchy skin that appears scaly, rough, and red. The symptoms can range from mild to severe. Ichthyosis can affect only the skin, but some forms of the disease can affect internal organs as well. There are more than 20 different types of ichthyosis. Some types are inherited at the birth and other types are acquired during adulthood. The treatment helps reduce the redness of the skin, thickness of the scales, and itching.

Market Dynamics:

Rise in burden of fish skin disease, rise in awareness among people, increase in demand for safe, effective treatments & therapies, and introduction of novel treatments/therapies by market players are major factors expected to propel growth of the global fish skin disease market.

For instance, in April 2023, Kerecis announced the launch of the MariGen Shield, a solution that combines the company’s fish-skin graft and a silicone contact layer to treat chronic and complex wounds. The silicone contact layer anchors the round graft in position, help safeguard granulating wound and the fish-skin graft following the application of a protective cover dressing.

Moreover, in October 2021, Kerecis received the Food and Drug Administration (FDA) marketing authorisation for Omega3 SurgiBind. It is an implantable fish-skin graft intended for use in plastic and reconstructive surgery. It is indicated for strengthening weak soft tissue in patients who require soft tissue repair, or reinforcement in plastic or reconstructive surgery.

Key features of the study:

• This report provides in-depth analysis of the global fish skin disease market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global fish skin disease market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Zoetis Inc., Biomin, Nutreco, Skretting, Alltech, AquaBounty Technologies, Pharmaq AS, Novartis AG, Merck Animal Health, Novartis, Intervet Inc., Benchmark Holdings, MSD Animal Health, Elanco Animal Health, and Phibro Animal Health Corporation, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global fish skin disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fish skin disease market.

Detailed Segmentation:

• Global Fish Skin Disease Market, Type of Disease:

Bacterial Infections

Parasitic Infections

Viral Infections

Fungal Infections

• Global Fish Skin Disease Market, By Treatment Type:

Antibiotics

Vaccines

Probiotics

Phage Therapy

Other Natural Treatments

• Global Fish Skin Disease Market, By Fish Species:

Salmon

Trout

Tilapia

Catfish

Others

• Global Fish Skin Disease Market, By End User:

Aquaculture Producers

Fisheries

Other Organizations Involved in Fish Production

• Global Fish Skin Disease Market, By Geography:

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

• Company Profiles:

Zoetis Inc.

Biomin

Nutreco

Skretting

Alltech

AquaBounty Technologies

Pharmaq AS

Novartis AG

Merck Animal Health

Novartis

Intervet Inc.

Benchmark Holdings

MSD Animal Health

Elanco Animal Health

Phibro Animal Health Corporation